USPTO serial 90759395
RHENIUM SCT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 6, 2025
- Examiner
- LEE, OLIVIA SUNMIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RHENIUM SCT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kari Moyer-Henry
Kari Moyer-Henry LEWIS KOHN & WALKER LLP17085 VIA DEL CAMPOSAN DIEGO, CA 92127United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cancer, namely, radio therapeutic preparations and radio diagnostic preparations used in the application of radioisotopes and radiation for medical purposes in the nature of nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy, diagnostics and therapy of pain, diagnostics and therapy of inflammations, diagnostics and therapy of metabolic disorders, palliative therapy, ablative therapy, positrons emission tomography, emission tomography with single photons, x-ray diagnostics, gamma spectrometry, nuclear spin tomography, scintigraphy, and dosimetry | ACTIVE | Dec 1, 2024 |
| 010 | Medical instruments and apparatus for dosimetry purposes in the field of radiotherapy, namely, apparatus for radiation therapy with radio therapeutic substance compounds; containers specially designed for holding radiopharmaceuticals sold as an integral component of apparatus for radiation therapy with radio therapeutic substance compounds; radiation dosimeters for assessing therapeutic doses of radiation delivered to patients; medical devices and instruments for introducing pharmaceutical preparations and diagnostic preparations into the human body, namely, radioactive isotope generators being medical radiation apparatus and microfluidics instruments being radioisotope therapy apparatus for therapy with radio therapeutic substance compounds; medical apparatus and instruments for diagnostic radiopharmaceutical use for the application of pharmaceutical preparations and diagnostic preparations, namely, apparatus for radiation therapy with radio therapeutic substance compounds; radioisotope therapy apparatus and instruments for the application of pharmaceutical preparations and diagnostic preparations, namely, apparatus for radiation therapy with radio therapeutic substance compounds; control, regulation and measuring apparatuses, namely, scintillation counters sold as an integral component of medical radiation apparatus, medical dose meter that measures the total radiation dose received by a patient during a diagnostic procedure, and radiation dosimeters for assessing therapeutic doses of radiation delivered to patients, all the foregoing comprising parts of medical instruments and devices for radiation therapy with a radio therapeutic substance | ACTIVE | Dec 1, 2024 |
| 044 | Medical services, particularly services in the field of radiologic and nuclear-medical medicine, radiation oncology and for the treatment of skin cancer, none of the foregoing services involving stem cell therapy | ACTIVE | Dec 1, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OncoBeta International GmbH
- Other trademarks owned by OncoBeta International GmbH
- Other trademarks owned by OncoBeta International GmbH
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named RHENIUM SCT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 6, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 6, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 17, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 17, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 8, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 7, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 30, 2024 | IUAF | USE AMENDMENT FILED | — |
| Dec 30, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 18, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 18, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 18, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 18, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 28, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 26, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 26, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 26, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 1, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 29, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 29, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 29, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 4, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 2, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 2, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 2, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 30, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 28, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 28, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 28, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 17, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 4, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 17, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 9, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 10, 2021 | NWAP | NEW APPLICATION ENTERED | — |